New hires and promotions in the biopharma industry, including: Altrubio, Eton, Healx, Mind Medicine, Nouscom, OSE, Tonix.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Autolus, Galderma, Gilead, Hua, Maplight, Merus, MBX, Revolution Medicines, Senti, Soligenix.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Advanz, Anavex, Aop Orphan, Beigene, Cevomed, Exelixis, Gsk, Kelun-Biotech, Lin, Novartis, Oncopeptides, Satsuma, Tuhura, Valneva.

Biopharmas raising money in public or private financings, including: Secretome, Transcode.

New hires and promotions in the biopharma industry, including: Biogene, Fate, Preveceutical, Senti.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alector, PTC, Outlook.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Acadia, Adcendo, Agenus, Alector, Duality Biologics, Empyrean, Eos, Idorsia, Kronos, PTC, Saniona.

A quick look back at top stories.

The top 10 biopharma stock gainers and losers for the week.